In the BioHarmony Drug Report Database
Spironolactone
Aldactone, Carospir (spironolactone) is a small molecule pharmaceutical. Spironolactone was first approved as Aldactone on 1982-12-30. It is used to treat ascites, edema, heart failure, hirsutism, and hyperaldosteronism amongst others in the USA. The pharmaceutical is active against mineralocorticoid receptor. Aldactone’s patent is valid until 2036-10-28 (FDA).
Trade Name
|
Aldactone, Carospir |
|---|---|
Common Name
|
spironolactone |
ChEMBL ID
|
CHEMBL1393 |
Indication
|
ascites, edema, heart failure, hirsutism, hyperaldosteronism, hypertension, hypokalemia |
Drug Class
|
Antimineralocorticoid; Steroidal antiandrogen |
Image (chem structure or protein)